323 related articles for article (PubMed ID: 19209166)
1. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment.
Münch A; Söderholm JD; Ost A; Ström M
Am J Gastroenterol; 2009 Mar; 104(3):679-85. PubMed ID: 19209166
[TBL] [Abstract][Full Text] [Related]
2. Dihydroxy bile acids increase mucosal permeability and bacterial uptake in human colon biopsies.
Münch A; Ström M; Söderholm JD
Scand J Gastroenterol; 2007 Oct; 42(10):1167-74. PubMed ID: 17852874
[TBL] [Abstract][Full Text] [Related]
3. Budesonide treatment and expression of inducible nitric oxide synthase mRNA in colonic mucosa in collagenous colitis.
Bonderup OK; Hansen JB; Madsen P; Vestergaard V; Fallingborg J; Teglbjaerg PS
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1095-9. PubMed ID: 16957516
[TBL] [Abstract][Full Text] [Related]
4. Anorectal function in patients with collagenous colitis in active and clinically quiescent phase, in comparison with healthy controls.
Walter SA; Münch A; Ost A; Ström M
Neurogastroenterol Motil; 2010 May; 22(5):534-8, e118. PubMed ID: 20156310
[TBL] [Abstract][Full Text] [Related]
5. Low levels of bile acids increase bacterial uptake in colonic biopsies from patients with collagenous colitis in remission.
Münch A; Söderholm JD; Ost A; Carlsson AH; Magnusson KE; Ström M
Aliment Pharmacol Ther; 2011 Apr; 33(8):954-60. PubMed ID: 21366635
[TBL] [Abstract][Full Text] [Related]
6. Colonic mucosal tears in collagenous colitis.
Wickbom A; Lindqvist M; Bohr J; Ung KA; Bergman J; Eriksson S; Tysk C
Scand J Gastroenterol; 2006 Jun; 41(6):726-9. PubMed ID: 16716973
[TBL] [Abstract][Full Text] [Related]
7. Budesonide for the treatment of collagenous colitis: first results of a pilot trial.
Tromm A; Griga T; Möllmann HW; May B; Müller KM; Fisseler-Eckhoff A
Am J Gastroenterol; 1999 Jul; 94(7):1871-5. PubMed ID: 10406251
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide.
Miehlke S; Madisch A; Voss C; Morgner A; Heymer P; Kuhlisch E; Bethke B; Stolte M
Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1115-9. PubMed ID: 16305725
[TBL] [Abstract][Full Text] [Related]
9. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
[TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: budesonide treatment for collagenous colitis.
Feyen B; Wall GC; Finnerty EP; DeWitt JE; Reyes RS
Aliment Pharmacol Ther; 2004 Oct; 20(7):745-9. PubMed ID: 15379834
[TBL] [Abstract][Full Text] [Related]
11. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Miehlke S; Madisch A; Kupcinskas L; Petrauskas D; Böhm G; Marks HJ; Neumeyer M; Nathan T; Fernández-Bañares F; Greinwald R; Mohrbacher R; Vieth M; Bonderup OK;
Gastroenterology; 2014 May; 146(5):1222-30.e1-2. PubMed ID: 24440672
[TBL] [Abstract][Full Text] [Related]
12. Oral pH-modified release budesonide for treatment of inflammatory bowel disease, collagenous and lymphocytic colitis.
Gross V
Expert Opin Pharmacother; 2008 May; 9(7):1257-65. PubMed ID: 18422482
[TBL] [Abstract][Full Text] [Related]
13. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis.
Bajor A; Kilander A; Gälman C; Rudling M; Ung KA
Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1643-9. PubMed ID: 17094773
[TBL] [Abstract][Full Text] [Related]
14. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study.
Wagner M; Peterson CG; Stolt I; Sangfelt P; Agnarsdottir M; Lampinen M; Carlson M
Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab in budesonide and methotrexate refractory collagenous colitis.
Münch A; Ignatova S; Ström M
Scand J Gastroenterol; 2012 Jan; 47(1):59-63. PubMed ID: 22149977
[TBL] [Abstract][Full Text] [Related]
16. Microscopic colitis: an unfamiliar but treatable disease.
van der Wouden EJ; Karrenbeld A; Kleibeuker JH; Dijkstra G
Neth J Med; 2009 Feb; 67(2):41-5. PubMed ID: 19299845
[TBL] [Abstract][Full Text] [Related]
17. Mucosal tear in collagenous colitis.
Dunzendorfer T; Wilkins S; Johnson R
Clin Gastroenterol Hepatol; 2009 Sep; 7(9):e57. PubMed ID: 18691941
[No Abstract] [Full Text] [Related]
18. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial.
Bonderup OK; Hansen JB; Teglbjaerg PS; Christensen LA; Fallingborg JF
Gut; 2009 Jan; 58(1):68-72. PubMed ID: 18669576
[TBL] [Abstract][Full Text] [Related]
19. After budesonide, what next for collagenous colitis?
Pardi DS
Gut; 2009 Jan; 58(1):3-4. PubMed ID: 19091826
[No Abstract] [Full Text] [Related]
20. Increased uptake of non-pathogenic E. coli via the follicle-associated epithelium in longstanding ileal Crohn's disease.
Keita AV; Salim SY; Jiang T; Yang PC; Franzén L; Söderkvist P; Magnusson KE; Söderholm JD
J Pathol; 2008 Jun; 215(2):135-44. PubMed ID: 18348161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
